Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Update $medh: From OTC - Background checks are in good standing, & am reaching out to Sig Stock Transfer & Jason to confirm the Transfer Agent feed is in good standing. Once confirmed we will invoice the annual fee & send the IQ Agreement to finalize the application approval.
— the 1 & Only HANS (@The1OnlyHans) April 24, 2024
This group took a fantastic shell 3 years ago and have only decimated its structure.
Massive dilution last 3-4 years.
Outstanding Shares
903,263,385
04/12/2024
More shares to be diluted soon.
Considering setting up a company with one pothead (cannabis user) to be a part-time dog walker and then just gift that company to Hans so he can at least show some revenue on the books.
Since we got the time… anyone suggest a good name for the Company?
Puff & Paws 🐾 Walkers
Bongs & Bark
2 to 52 more weeks to go!
What’s the problem here? Literally no ophthalmic company wants in at the starting line?
Not one interested investor to lift the company up?
Q1 coming and going
They are diluting everyone out of their longterm positions. Expecting Billion OS soon
Outstanding Shares
903,263,385
03/04/2024
Unsure if that’s accurate, shows 200 mil shares increased on OS
https://www.otcmarkets.com/stock/CUBT/security
Outstanding Shares
703,263,385
02/15/2024
They haven’t updated this but I’m guessing the next time they do it will show more dilution
They are diluting more shares.
Guess Aegis Capital Corp. couldn’t get it done.
Garr and Michaels funding issues? Should be a slam dunk with two active drug programs
More dilution? Or iRobert selling the newly bought shares?
The 160 million shares diluted though now explains why we could never arrive to a higher SP.
I hope they stop the bleeding…
Nice buying iRobot! Glad you loaded up more shares! That shows conviction!
And the OS continues to grow as they dilute.
Outstanding Shares
703,263,385
02/15/2024
No funding news yet.
The audacity… that’s exactly how not to attract investors with silly RS talk.
Can’t even get current nor file official financial and says that.
Get 10-20 unit’s operating with a valid accounting team then talk like that.
awesome to see we have a CD56 monoclonal antibody product $$$$$$
https://www.acrobiosystems.com/L-1666-CD56.html?gad_source=1&gclid=EAIaIQobChMIibSKjb-whAMVczrUAR3DbA-BEAAYASAAEgJGWfD_BwE
Name Research Code Research Phase Company Indications Clinical Trials
Lorvotuzumab mertansine BB-10901; IMGN-901; huN-901-DM1; IMGN-901-TAP; huN-901-SPP-DM1 Phase 2 Clinical Immunogen Inc Ovarian Neoplasms; Leukemia; Rhabdomyosarcoma; Carcinoma, Merkel Cell; Small Cell Lung Carcinoma; Wilms Tumor; Multiple Myeloma; Sarcoma, Synovial; Neurofibrosarcoma; Neuroblastoma; Carcinoma, Small Cell
Details
GD2/CD56 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) bi-4SCAR GD2/CD56 Phase 2 Clinical Shenzhen Geno-Immune Medical Institute Neoplasms
Details
CUBT-906 CUBT-906 Phase 2 Clinical Curative Biotechnology Inc
Load up and check this out!
CD56
Brief Information
Name:Neural cell adhesion molecule 1
Target Synonym:Neural cell adhesion molecule 1,CD56,NCAM1,NCAM,Neural Cell Adhesion Molecule, NCAM,CD56 Antigen,N-CAM-1,MSK39,NCAM-1,Antigen Recognized By Monoclonal Antibody 5.1H11
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 2 Clinical
Yep. Very true! Lol
Have to hope Hans has Financials prepared and ready to submit. Once revenue is transparent that will be a game changer!
Mitesco shareholder update
https://finance.yahoo.com/news/mitesco-provides-shareholder-141200469.html
Any chance our CEO’s Paul and Richard can take a nice professional headshot for their LinkedIn photos and CUBT website?
Paul looks like he’s wearing a robe until you look closely and Richard looks like he took it himself and is looking away.
Upgrade them pics of our leaders!
Optimistic to think we go $0.30 with two drug programs
Could they be building the cancer drug up as a stepping stone into the metformin filing? Two optimistic drug programs could drive this >$0.75 …
Curative Biotechnology funding and FDA IND application soon? When ?
Dilution = Pollution
Yes! Trading Soon!!! Dazed name change complete
Update- $medh
— the 1 & Only HANS (@The1OnlyHans) February 7, 2024
Name change complete
Dazed=> MedX. #OTC access next.
FINs upload.
Pink Current. pic.twitter.com/kNbKhLOoRB
If Hans were ever indicted then I would believe you.
At this point you are just scared of your own delusion.
“Did I mention we are a publicly traded company. OTC ticker (MEDH)
DM me! Let's talk about a 2M capital raise.”
https://www.linkedin.com/posts/hansenriquez_lfg-consumptionlounge-franchisebusiness-activity-7158817861182914562-4Kl3
When Rockets?
Who/What is this? 72hrs or foreclosure??
Is this the Lazydaze location or something else?
https://www.linkedin.com/posts/hansenriquez_realestate-rei-franchise-activity-7157902188881551361-hp0n
First time I say to pdgood…
The Jeremy Amsden (CNNA) connection is very interesting
Outstanding Shares
703,263,385
What’s with all the dilution?
“As we all know, 2023 was a horrible year for initial public offerings in biotech. However, the IPO market seems to have come alive in early 2024 with five companies jumping into the fray—Alto Neuroscience, ArriVent Biopharma, CG Oncology, Kyverna Therapeutics and Metagenomi.”
When Curative Biotech?
https://www.biospace.com/article/2024-brings-surprising-early-surge-of-biotech-ipos-/
iRobot dumping shares?